These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19786720)

  • 1. Hepatotoxicity and antituberculosis therapy: time to revise UK guidance?
    Walker NF; Kliner M; Turner D; Bhagani S; Cropley I; Hopkins S; Lipman M
    Thorax; 2009 Oct; 64(10):918. PubMed ID: 19786720
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication errors with antituberculosis therapy in an inpatient, academic setting: forgotten but not gone.
    Jen SP; Zucker J; Buczynski P; Odenigbo C; Cennimo D; Patrawalla A
    J Clin Pharm Ther; 2016 Feb; 41(1):54-8. PubMed ID: 26763664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs.
    Marks DJ; Dheda K; Dawson R; Ainslie G; Miller RF
    Int J STD AIDS; 2009 May; 20(5):339-45. PubMed ID: 19386972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
    Sharma SK; Singla R; Sarda P; Mohan A; Makharia G; Jayaswal A; Sreenivas V; Singh S
    Clin Infect Dis; 2010 Mar; 50(6):833-9. PubMed ID: 20156055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.
    Marzuki OA; Fauzi AR; Ayoub S; Kamarul Imran M
    Singapore Med J; 2008 Sep; 49(9):688-93. PubMed ID: 18830542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short communication: antituberculosis drug-induced hepatotoxicity is unexpectedly low in HIV-infected pulmonary tuberculosis patients in Malawi.
    Tostmann A; Boeree MJ; Harries AD; Sauvageot D; Banda HT; Zijlstra EE
    Trop Med Int Health; 2007 Jul; 12(7):852-5. PubMed ID: 17596252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.
    Tostmann A; van den Boogaard J; Semvua H; Kisonga R; Kibiki GS; Aarnoutse RE; Boeree MJ
    Trop Med Int Health; 2010 Feb; 15(2):268-72. PubMed ID: 20409289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of hepatotoxicity and antituberculosis therapy in South Carolina.
    Dowda M; Sy FS; Dowda H; Pozsik CJ
    J S C Med Assoc; 1998 Jan; 94(1):16-20. PubMed ID: 9473867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity Due to Antituberculosis Therapy among Paediatric Patients Seen at the University of Ilorin Teaching Hospital, North Central Nigeria.
    Aishatu G; Rasheedah I; Wahab J; Sheni M; Damilola O; Adeniyi O
    Ethiop J Health Sci; 2017 Mar; 27(2):115-120. PubMed ID: 28579706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in reintroducing tuberculosis medications after hepatotoxicity.
    Saukkonen J
    Clin Infect Dis; 2010 Mar; 50(6):840-2. PubMed ID: 20156056
    [No Abstract]   [Full Text] [Related]  

  • 11. Antituberculosis drugs and hepatotoxicity.
    Sharma SK
    Infect Genet Evol; 2004 Jun; 4(2):167-70. PubMed ID: 15157635
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?
    Jasmer RM; Daley CL
    Am J Respir Crit Care Med; 2003 Mar; 167(6):809-10. PubMed ID: 12623855
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatotoxicity caused by antituberculosis drugs in pediatrics].
    Reto Valiente LV; Castillo Vergara J; Pichilingue Reto P; Pichilingue Prieto OA
    Rev Gastroenterol Peru; 2005; 25(4):362-5. PubMed ID: 16333392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic drug monitoring in patients exposed to antitubercular treatment].
    Domínguez JP; Amenábar E; Mendoza F; Pivet H; Palacios L; Lagos A; Diaz N; Calderón J; Cardenas R; Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):733-7. PubMed ID: 7156604
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring and management of antituberculosis drug induced hepatotoxicity.
    Agal S; Baijal R; Pramanik S; Patel N; Gupte P; Kamani P; Amarapurkar D
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1745-52. PubMed ID: 16246196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.
    Tostmann A; Boeree MJ; Aarnoutse RE; de Lange WC; van der Ven AJ; Dekhuijzen R
    J Gastroenterol Hepatol; 2008 Feb; 23(2):192-202. PubMed ID: 17995946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patients.
    Yimer G; Aderaye G; Amogne W; Makonnen E; Aklillu E; Lindquist L; Yamuah L; Feleke B; Aseffa A
    PLoS One; 2008 Mar; 3(3):e1809. PubMed ID: 18350147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients.
    Ohkawa K; Hashiguchi M; Ohno K; Kiuchi C; Takahashi S; Kondo S; Echizen H; Ogata H
    Clin Pharmacol Ther; 2002 Aug; 72(2):220-6. PubMed ID: 12189369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hepatotoxicity induced by antituberculosis drugs.
    Devoto FM; González C; Iannantuono R; Serra HA; González CD; Sáenz C
    Acta Physiol Pharmacol Ther Latinoam; 1997; 47(4):197-202. PubMed ID: 9504179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis.
    Gülbay BE; Gürkan OU; Yildiz OA; Onen ZP; Erkekol FO; Baççioğlu A; Acican T
    Respir Med; 2006 Oct; 100(10):1834-42. PubMed ID: 16517138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.